168 related articles for article (PubMed ID: 24102525)
1. Inhibition of anthrax lethal factor by curcumin and chemically modified curcumin derivatives.
Antonelli AC; Zhang Y; Golub LM; Johnson F; Simon SR
J Enzyme Inhib Med Chem; 2014 Oct; 29(5):663-9. PubMed ID: 24102525
[TBL] [Abstract][Full Text] [Related]
2. Metalloproteinase inhibitors, nonantimicrobial chemically modified tetracyclines, and ilomastat block Bacillus anthracis lethal factor activity in viable cells.
Kocer SS; Walker SG; Zerler B; Golub LM; Simon SR
Infect Immun; 2005 Nov; 73(11):7548-57. PubMed ID: 16239558
[TBL] [Abstract][Full Text] [Related]
3. Probing the S2' Subsite of the Anthrax Toxin Lethal Factor Using Novel N-Alkylated Hydroxamates.
Kurbanov EK; Chiu TL; Solberg J; Francis S; Maize KM; Fernandez J; Johnson RL; Hawkinson JE; Walters MA; Finzel BC; Amin EA
J Med Chem; 2015 Nov; 58(21):8723-33. PubMed ID: 26492514
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the proteolytic activity of anthrax lethal factor by aminoglycosides.
Lee LV; Bower KE; Liang FS; Shi J; Wu D; Sucheck SJ; Vogt PK; Wong CH
J Am Chem Soc; 2004 Apr; 126(15):4774-5. PubMed ID: 15080670
[TBL] [Abstract][Full Text] [Related]
5. Cross-inhibition between furin and lethal factor inhibitors.
Peinado JR; Kacprzak MM; Leppla SH; Lindberg I
Biochem Biophys Res Commun; 2004 Aug; 321(3):601-5. PubMed ID: 15358148
[TBL] [Abstract][Full Text] [Related]
6. Low molecular weight inhibitors of the protease anthrax lethal factor.
Dalkas GA; Papakyriakou A; Vlamis-Gardikas A; Spyroulias GA
Mini Rev Med Chem; 2008 Mar; 8(3):290-306. PubMed ID: 18336349
[TBL] [Abstract][Full Text] [Related]
7. Highly predictive support vector machine (SVM) models for anthrax toxin lethal factor (LF) inhibitors.
Zhang X; Amin EA
J Mol Graph Model; 2016 Jan; 63():22-8. PubMed ID: 26615468
[TBL] [Abstract][Full Text] [Related]
8. Proteolytic assay-based screening identifies a potent inhibitor of anthrax lethal factor.
Park HC; Sung SR; Lim SM; Lee JS; Kim SK; Yoon MY
Microb Pathog; 2012 Aug; 53(2):109-12. PubMed ID: 22561400
[TBL] [Abstract][Full Text] [Related]
9. Selectively guanidinylated derivatives of neamine. Syntheses and inhibition of anthrax lethal factor protease.
Jiao GS; Simo O; Nagata M; O'Malley S; Hemscheidt T; Cregar L; Millis SZ; Goldman ME; Tang C
Bioorg Med Chem Lett; 2006 Oct; 16(19):5183-9. PubMed ID: 16870442
[TBL] [Abstract][Full Text] [Related]
10. Quantitative Determination of Lethal Toxin Proteins in Culture Supernatant of Human Live Anthrax Vaccine Bacillus anthracis A16R.
Zai X; Zhang J; Liu J; Liu J; Li L; Yin Y; Fu L; Xu J; Chen W
Toxins (Basel); 2016 Feb; 8(3):. PubMed ID: 26927174
[TBL] [Abstract][Full Text] [Related]
11. Identification of a lead small-molecule inhibitor of anthrax lethal toxin by using fluorescence-based high-throughput screening.
Wei D; Bu Z; Yu A; Li F
BMB Rep; 2011 Dec; 44(12):811-5. PubMed ID: 22189685
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel non-hydroxamate anthrax toxin lethal factor inhibitors by topomeric searching, docking and scoring, and in vitro screening.
Chiu TL; Solberg J; Patil S; Geders TW; Zhang X; Rangarajan S; Francis R; Finzel BC; Walters MA; Hook DJ; Amin EA
J Chem Inf Model; 2009 Dec; 49(12):2726-34. PubMed ID: 19928768
[TBL] [Abstract][Full Text] [Related]
13. Efficient synthetic inhibitors of anthrax lethal factor.
Forino M; Johnson S; Wong TY; Rozanov DV; Savinov AY; Li W; Fattorusso R; Becattini B; Orry AJ; Jung D; Abagyan RA; Smith JW; Alibek K; Liddington RC; Strongin AY; Pellecchia M
Proc Natl Acad Sci U S A; 2005 Jul; 102(27):9499-504. PubMed ID: 15983377
[TBL] [Abstract][Full Text] [Related]
14. Examination of anthrax lethal factor inhibition by siderophores, small hydroxamates, and protamine.
Thomas M; Castignetti D
J Microbiol Immunol Infect; 2009 Aug; 42(4):284-9. PubMed ID: 19949750
[TBL] [Abstract][Full Text] [Related]
15. Insights into the anthrax lethal factor-substrate interaction and selectivity using docking and molecular dynamics simulations.
Dalkas GA; Papakyriakou A; Vlamis-Gardikas A; Spyroulias GA
Protein Sci; 2009 Aug; 18(8):1774-85. PubMed ID: 19585464
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic differences between in vitro assays for hydrazone-based small molecule inhibitors of anthrax lethal factor.
Hanna ML; Tarasow TM; Perkins J
Bioorg Chem; 2007 Feb; 35(1):50-8. PubMed ID: 16949126
[TBL] [Abstract][Full Text] [Related]
17. Novel small-molecule inhibitors of anthrax lethal factor identified by high-throughput screening.
Schepetkin IA; Khlebnikov AI; Kirpotina LN; Quinn MT
J Med Chem; 2006 Aug; 49(17):5232-44. PubMed ID: 16913712
[TBL] [Abstract][Full Text] [Related]
18. Toxins of Bacillus anthracis.
Brossier F; Mock M
Toxicon; 2001 Nov; 39(11):1747-55. PubMed ID: 11595637
[TBL] [Abstract][Full Text] [Related]
19. Purified Bacillus anthracis lethal toxin complex formed in vitro and during infection exhibits functional and biological activity.
Panchal RG; Halverson KM; Ribot W; Lane D; Kenny T; Abshire TG; Ezzell JW; Hoover TA; Powell B; Little S; Kasianowicz JJ; Bavari S
J Biol Chem; 2005 Mar; 280(11):10834-9. PubMed ID: 15644338
[TBL] [Abstract][Full Text] [Related]
20. A semisynthesis platform for investigating structure-function relationships in the N-terminal domain of the anthrax Lethal Factor.
Pentelute BL; Barker AP; Janowiak BE; Kent SB; Collier RJ
ACS Chem Biol; 2010 Apr; 5(4):359-64. PubMed ID: 20180595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
